Gilead Sciences Inc
(GILD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,643,000 | 7,588,000 | 11,508,000 | 8,712,000 | 10,285,000 |
| Marketable Securities | 16,355,000 | 17,922,000 | 16,879,000 | 12,384,000 | 3,830,000 |
| Receivables | 3,775,000 | 3,851,000 | 4,122,000 | 4,478,000 | 4,034,000 |
| Inventories | 885,000 | 801,000 | 1,144,000 | 1,408,000 | 1,474,000 |
| TOTAL | $30,258,000 | $31,823,000 | $35,317,000 | $28,592,000 | $21,424,000 |
| Non-Current Assets | |||||
| PPE Net | 3,415,000 | 3,295,000 | 3,100,000 | 3,012,000 | 2,922,000 |
| Investments And Advances | 8,104,000 | 11,184,000 | 12,973,000 | 15,480,000 | 19,902,000 |
| Intangibles | 20,962,000 | 21,259,000 | 9,514,000 | 9,723,000 | 9,933,000 |
| Other Non-Current Assets | 2,642,000 | 2,722,000 | 3,758,000 | 3,456,000 | 3,520,000 |
| TOTAL | $35,123,000 | $38,460,000 | $29,345,000 | $31,671,000 | $36,277,000 |
| Total Assets | $65,381,000 | $70,283,000 | $64,662,000 | $60,263,000 | $57,701,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,497,000 | 2,747,000 | 1,747,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 711,000 | 814,000 | 696,000 | 819,000 | 944,000 |
| Accrued Expenses | 5,048,000 | 4,704,000 | 4,672,000 | 4,682,000 | 4,712,000 |
| TOTAL | $10,670,000 | $11,635,000 | $9,597,000 | $8,492,000 | $8,282,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,228,000 | 31,353,000 | 27,774,000 | 26,738,000 | 26,321,000 |
| Other Non-Current Liabilities | 6,831,000 | 6,765,000 | 2,043,000 | 1,946,000 | 2,184,000 |
| TOTAL | $34,060,000 | $38,147,000 | $29,811,000 | $28,680,000 | $28,502,000 |
| Total Liabilities | $44,730,000 | $49,782,000 | $39,408,000 | $37,172,000 | $36,784,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,300,261 | 1,309,968 | 1,306,269 | 1,305,926 | 1,306,728 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 19,196,000 | 19,012,000 | 23,689,000 | 21,823,000 | 19,564,000 |
| Other shareholders' equity | -110,000 | 224,000 | 658,000 | 534,000 | 736,000 |
| TOTAL | $20,651,000 | $20,501,000 | $25,254,000 | $23,091,000 | $20,917,000 |
| Total Liabilities And Equity | $65,381,000 | $70,283,000 | $64,662,000 | $60,263,000 | $57,701,000 |